查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1715611

心臟安全服務市場按服務類型、類型、應用和最終用戶分類－2025-2030 年全球預測

Cardiac Safety Services Market by Service Type, Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計 2023 年心臟安全服務市場價值將達到 12.2 億美元，2024 年將成長至 13.3 億美元，到 2030 年將達到 23.4 億美元，複合年成長率為 9.71%。

主要市場統計數據
基準年2023年 12.2億美元
預計2024年 13.3億美元
預測年份 2030 23.4億美元
複合年成長率（%） 9.71%

心臟安全服務在確保新的醫療創新以不折不扣的安全性推向市場方面發揮著至關重要的作用。在當今快速發展的醫療保健環境中，這些服務在改善患者治療效果的同時，也保持了監管的完整性。透過嚴格的測試方法、尖端的診斷技術以及全面的心血管評估方法，該行業成功地彌合了臨床研究與患者照護之間的差距。

該報告對心臟安全服務領域進行了深入研究，檢驗了當前趨勢、變革促進因素、細分見解、區域和公司特定動態。其目標不僅是提供市場發展的概述，而且還要為相關人員提供資源，以便他們在日益激烈的競爭環境中做出明智的決策並抓住新的機會。

隨著先進技術和數據分析的普及，從初步篩檢到最終的法規遵循，心臟安全工作流程的每個步驟都得到了顯著增強。隨著該領域的不斷成熟，創新解決方案的持續整合將開啟臨床安全評估的新篇章，有望提高準確性、縮短時間並改善患者的治療效果。

一場變革將重新定義心臟安全服務的範式

近年來，隨著技術進步的加快和監管要求的不斷變化，心臟安全服務領域發生了變革性的變化。從遠端監控系統到人工智慧增強診斷演算法的數位健康工具的快速整合正在重塑傳統方法並加速我們評估心血管安全的方式。

這種轉型轉變正在推動整個產業的變革，其中數據主導的洞察力補充了傳統的臨床評估。相關人員擴大掌握準確、即時的資訊，這不僅可以改善潛在治療方法的早期影響評估，而且還為法規遵從性提供了可靠的縱向數據。雲端運算、高效能分析和下一代成像技術的融合為更靈活、更具適應性的安全評估鋪平了道路。

此外，從製藥巨頭到創新新興企業的多個領域的合作正在加強生態系統並為跨行業協同效應創造機會。這種專業知識的整合正在提高流程效率、縮短臨床試驗週期並確保安全始終處於治療開發創新的前沿。最終，這些變化代表著模式轉移，其中品質、精確度和速度至關重要，開創了心血管安全保障的新時代。

跨服務類型、應用程式和最終用戶的關鍵細分洞察

心臟安全服務市場的細分分析揭示了一個多維框架，突顯了該行業的多樣性和複雜性。在根據服務類型分析市場時，該研究區分了血壓測量服務、心血管影像服務、心電圖或動態心電圖測量服務以及全面的 QT 測試。每個類別都反映了患者和治療評估的細微方面，並有助於更廣泛地了解心血管風險管理和臨床安全。

關於服務模型，我們區分整合服務和獨立服務。這種二分法不僅闡明了營運動態，而且揭示了服務交付的不同整體性水平，突顯了頻譜解決方案相對於分隔的、特定任務的方法的優勢。當根據應用來審視市場時，細分變得更加細化，藥物和設備開發與監管合規要求之間存在明顯的分歧。該部門幫助相關人員了解現代臨床試驗所需的雙重關注，即在技術創新和嚴格的監督框架之間取得平衡。

此外，按最終用戶細分可提供包括委外研發機構、製藥和生物製藥公司以及研究機構在內的觀點。這種多層次的使用者類型分類凸顯了不同的相關人員有自己的優先事項和營運挑戰，從而需要製定量身定做的策略。整合這些不同的細分因素可以提供對市場的整體情況，使決策者能夠策略性地提供滿足各個細分市場複雜需求的產品。

透過將這些方面納入分析框架，報告明確指出，一刀切的做法不再可行。相反，針對服務類型、交付方式、應用重點和最終用戶要求等具體情況的客製化策略對於在當今快速發展的心臟安全服務市場中取得成功至關重要。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 全球心臟相關疾病發生率不斷上升，新藥開發需求不斷成長
      • 製藥公司擴大使用CRO外包服務
    • 限制因素
      • 對心臟安全技術與現有醫療IT基礎設施整合的擔憂
    • 機會
      • 持續整合人工智慧和機器學習，提高心臟監測準確性
      • 增加公共和私人對新臨床研究的投資
    • 任務
      • 與心臟安全服務相關的監管合規性和獎勵
  • 市場區隔分析
    • 服務類型：對 Holter 監測服務的需求不斷成長，用於監測藥物對心率的影響
    • 類型：利用具有靈活性和精確心臟參數定位的獨立服務
    • 應用：藥物和醫療設備開發的重點增強了對心臟副作用的檢測
    • 最終使用者：心臟安全的創新和臨床試驗中合約研究組織不斷演變的角色
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 心臟安全服務市場（依服務類型）

  • 血壓測量服務
  • 心血管影像服務
  • ECG 或 Holter 監測服務
  • 徹底的QT研究

7. 心臟安全服務市場（按類型）

  • 整合服務
  • 獨立服務

8. 心臟安全服務市場（按應用）

  • 藥品和醫療設備開發
  • 監理合規要求

9. 心臟安全服務市場（依最終用戶）

  • 合約研究組織
  • 製藥和生物製藥
  • 研究組織

10.美洲心臟安全服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

11.亞太心臟安全服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

12.歐洲、中東和非洲心臟安全服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023年市場佔有率分析
  • 2023年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • ACM Global Laboratories
  • Advarra, Inc.
  • Banook Group
  • Biotrial
  • Celerion
  • Certara, Inc.
  • Charles River Laboratories International, Inc.
  • Circle Cardiovascular Imaging Inc.
  • Clario
  • Clyde Biosciences Limited
  • Eurofins Scientific SE
  • GE HealthCare Technologies Inc.
  • ICON PLC
  • IQVIA Holdings Inc.
  • Koninklijke Philips NV
  • Laboratory Corporation of America Holdings
  • Medpace, Inc.
  • MERIT CRO, Inc.
  • Metrion Biosciences Limited
  • Ncardia Services BV
  • NEXEL Co., Ltd.
  • Octagos Health, Inc.
  • Parexel International Corporation
  • PhysioStim SAS
  • PPD, Inc. by Thermo Fisher Scientific Inc.
  • Richmond Pharmacology Limited
  • Shanghai Medicilon Inc.
  • Worldwide Clinical Trials
Product Code: MRR-034230D3E2D5

The Cardiac Safety Services Market was valued at USD 1.22 billion in 2023 and is projected to grow to USD 1.33 billion in 2024, with a CAGR of 9.71%, reaching USD 2.34 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 1.22 billion
Estimated Year [2024] USD 1.33 billion
Forecast Year [2030] USD 2.34 billion
CAGR (%) 9.71%

Cardiac safety services play a pivotal role in ensuring that new medical innovations reach the market with an uncompromised safety profile. In today's fast-evolving healthcare environment, these services sustain regulatory integrity while enhancing patient outcomes. Through rigorous testing methodologies, cutting-edge diagnostic techniques, and a comprehensive approach to cardiovascular evaluations, the industry has successfully bridged the gap between clinical research and patient care.

This report provides an in-depth exploration of the cardiac safety services sector, examining current trends, transformation drivers, segmentation insights, and regional and company-specific dynamics. The objective is not only to outline the evolution of the market but also to serve as a resource that empowers stakeholders to make informed decisions and seize emerging opportunities in an increasingly competitive landscape.

With the proliferation of advanced technologies and data analytics, every step in the cardiac safety workflow-from preliminary screening to final regulatory compliance-has witnessed significant enhancements. As the sector continues to mature, ongoing integration of innovative solutions begins a new chapter in clinical safety evaluation, promising enhanced accuracy, reduced timelines, and improved patient outcomes.

Transformative Shifts Redefining the Cardiac Safety Services Paradigm

Recent years have witnessed transformative shifts in the cardiac safety services domain, driven by the accelerated pace of technological advancements and evolving regulatory demands. The rapid integration of digital health tools, from remote monitoring systems to AI-enhanced diagnostic algorithms, is reshaping traditional methodologies and accelerating the way cardiovascular safety is assessed.

These transformative shifts are catalyzing an industry-wide evolution where data-driven insights now complement traditional clinical evaluations. Stakeholders are increasingly equipped with precise, real-time information that not only improves the initial impact assessment of therapeutic candidates but also provides robust longitudinal data for regulatory compliance. The convergence of cloud computing, high-performance analytics, and next-generation imaging techniques has paved the way for more agile and adaptive safety assessments.

Moreover, collaborations across multiple sectors-ranging from pharmaceutical giants to innovative startups-are enhancing the ecosystem, creating opportunities for cross-industry synergy. This melding of expertise is driving improvements in process efficiencies, reducing the cycle time for clinical trials, and ensuring that safety remains at the forefront of innovation in therapeutic development. Ultimately, these changes signify a paradigm shift where quality, precision, and speed are paramount, precipitating a new era of cardiovascular safety assurance.

Key Segmentation Insights Across Service Types, Applications, and End Users

The segmentation analysis of the cardiac safety services market reveals a multidimensional framework that underscores the diversity and complexity of the industry. When analyzing the market based on service type, the study differentiates among blood pressure measurement services, cardiovascular imaging services, ECG or holter measurement services, and thorough QT studies. Each of these categories reflects a nuanced aspect of patient assessment and therapeutic evaluation, contributing to a broader understanding of cardiovascular risk management and clinical safety.

In terms of service models, the analysis distinguishes between integrated services and standalone services. This dichotomy not only provides clarity on operational dynamics but also illuminates the varying levels of comprehensiveness in service delivery, highlighting the benefits of full-spectrum solutions versus compartmentalized, task-specific approaches. Further granularity in the segmentation is observed when the market is examined based on applications, where there is a clear bifurcation between drug and device development and regulatory compliance requirements. This delineation helps stakeholders appreciate the dual focus required in modern clinical trials, balancing innovation with stringent oversight frameworks.

Additionally, the segmentation by end-user presents a perspective that includes contract research organizations, pharmaceutical and biopharma entities, and research institutes. This layered categorization of user types accentuates the tailored strategies employed by different stakeholders, each of whom carries unique priorities and operational challenges. The integration of these various segmentation factors provides a holistic view of the market, allowing decision-makers to strategically align their offerings with the intricacies of demand across different segments.

By embedding these dimensions into the analytical framework, the report clearly illustrates that a one-size-fits-all approach is no longer viable. Instead, a customized strategy that caters to the specifics of service type, delivery method, application focus, and end-user requirements is essential for success in today's rapidly evolving cardiac safety services market.

Based on Service Type, market is studied across Blood Pressure Measurement Services, Cardiovascular Imaging Services, ECG or Holter Measurement Services, and Thorough QT Studies.

Based on Type, market is studied across Integrated Services and Standalone Services.

Based on Application, market is studied across Drug & Device Development and Regulatory Compliance Requirements.

Based on End User, market is studied across Contract Research Organizations, Pharmaceutical & Biopharma, and Research Institutes.

Regional Insights Highlighting Evolving Market Dynamics

When evaluating the geographical dynamics of the cardiac safety services market, it is imperative to consider the distinct characteristics of three major regions: the Americas; Europe, Middle East & Africa; and Asia-Pacific. Each region exhibits unique trends and opportunities that drive their specific market behaviors.

In the Americas, a combination of well-established healthcare infrastructures and dynamic biopharma sectors has fostered an environment conducive to rapid technological adoption and innovation. Regulatory bodies in the region continue to emphasize the integration of advanced monitoring systems and stringent safety protocols. Meanwhile, Europe, Middle East & Africa present a mosaic of markets where consolidated healthcare systems and progressive regulatory frameworks promote cross-border collaborations and research initiatives. This region is characterized by both mature markets with robust safety standards and emerging markets that are adopting cutting-edge cardiac evaluation practices.

Asia-Pacific has emerged as a frontier for growth and innovation, buoyed by a rapidly expanding patient base and significant investments in healthcare technology. The region is becoming increasingly important for clinical trials, owing to a combination of cost-effectiveness and access to diverse patient populations. This geographic segmentation reinforces the necessity for localized strategies that address distinct regulatory, cultural, and economic circumstances, thereby highlighting how regional factors shape the evolution of cardiac safety services globally.

Overall, these regional insights signal that market dynamics are influenced not only by technological and methodological advancements but also by inherent regional disparities. By understanding these differences, stakeholders can design targeted strategies that effectively navigate the concurrent challenges and opportunities present in each region.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New York, North Carolina, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Company Insights Unveiling Leaders in Cardiac Safety Services

An analysis of the key companies driving the cardiac safety services market uncovers a vibrant landscape marked by both longstanding institutions and innovative newcomers. Industry leaders include organizations such as ACM Global Laboratories and Advarra, Inc., alongside influential players like Banook Group, Biotrial, and Celerion. These companies have garnered industry recognition for their expertise in integrating advanced methodologies and comprehensive clinical trial assessments.

Moreover, the market is further defined by the contributions of entities like Certara, Inc. and Charles River Laboratories International, Inc. which have historically set high standards for safety and regulatory compliance. Other influential companies such as Circle Cardiovascular Imaging Inc. and Clario exemplify the integration of state-of-the-art imaging and monitoring technologies, while Clyde Biosciences Limited and Eurofins Scientific SE underscore the importance of a multi-faceted analytical approach.

Outstanding market players also include GE HealthCare Technologies Inc., ICON PLC, and IQVIA Holdings Inc., whose expansive operational expertise has significantly shaped industry standards. Additionally, global brands such as Koninklijke Philips N.V. and Laboratory Corporation of America Holdings are innovating in the realms of diagnostic imaging and patient monitoring systems, respectively. Among other notable contributors are Medpace, Inc., MERIT CRO, Inc., and Metrion Biosciences Limited, which have each demonstrated a commitment to scientific rigor and process optimization.

A closer look at companies such as Ncardia Services B.V., NEXEL Co., Ltd., Octagos Health, Inc., and Parexel International Corporation further reveals a drive for innovation that not only enhances clinical outcomes but also optimizes operational efficiencies. Other key contributors, including PhysioStim SAS, PPD, Inc. by Thermo Fisher Scientific Inc., Richmond Pharmacology Limited, Shanghai Medicilon Inc., and Worldwide Clinical Trials, collectively ensure that the market remains agile, responsive, and primed to meet evolving demands.

This diverse representation of top-tier organizations reflects a robust competitive landscape and indicates a strong trend towards the amalgamation of technology, research, and patient-centric care within the global cardiac safety services market.

The report delves into recent significant developments in the Cardiac Safety Services Market, highlighting leading vendors and their innovative profiles. These include ACM Global Laboratories, Advarra, Inc., Banook Group, Biotrial, Celerion, Certara, Inc., Charles River Laboratories International, Inc., Circle Cardiovascular Imaging Inc., Clario, Clyde Biosciences Limited, Eurofins Scientific SE, GE HealthCare Technologies Inc., ICON PLC, IQVIA Holdings Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Medpace, Inc., MERIT CRO, Inc., Metrion Biosciences Limited, Ncardia Services B.V., NEXEL Co., Ltd., Octagos Health, Inc., Parexel International Corporation, PhysioStim SAS, PPD, Inc. by Thermo Fisher Scientific Inc., Richmond Pharmacology Limited, Shanghai Medicilon Inc., and Worldwide Clinical Trials. Actionable Recommendations for Industry Leaders

To maintain competitive advantages and drive sustained market growth, industry leaders need to adopt proactive strategies that address both current challenges and future opportunities in the cardiac safety services sector. Emphasizing the integration of advanced diagnostic tools and digital solutions is paramount. Stakeholders are encouraged to invest in high-throughput imaging technologies, automated analytical tools, and cloud-based data management systems that can substantially enhance the efficiency and accuracy of cardiac assessments.

Strategic investments in innovation should be complemented by a commitment to continuous workforce training. This approach ensures that clinical teams are proficient in the latest protocols and technologies, thereby reducing error margins and accelerating the pace at which therapeutic candidates advance through clinical pipelines. Furthermore, forming collaborative partnerships across research institutions and technology firms can enrich the available pool of expertise, foster innovative synergies, and ultimately deliver high-quality outcomes in clinical safety evaluations.

It is essential for decision-makers to adopt a segmented approach to market engagement, tailoring solutions to meet the unique needs of service types, applications, and end-user groups. A deep understanding of regional disparities will also empower companies to design localized strategies that reflect the distinct regulatory, cultural, and economic landscapes inherent in different geographies.

In addition, organizations should actively monitor the competitive environment through the integration of real-time data analytics. This enables a responsive management strategy that can swiftly adjust to emerging trends or regulatory shifts, thereby enabling a more agile operational model. In doing so, industry leaders can not only streamline operations but also preemptively mitigate potential risks associated with market volatility.

Ultimately, the pathway to sustained success in cardiac safety services lies in blending technological innovation with a robust, segmented market strategy. Leaders who can navigate the intricate tapestry of clinical, technological, and regulatory elements will be best positioned to spearhead the next wave of industry evolution.

Conclusion: Reflecting on the Evolving Cardiac Safety Paradigm

In conclusion, the cardiac safety services domain is evolving at an unprecedented pace, driven by technological breakthroughs, strategic collaborations, and comprehensive segmentation strategies that cater to a multi-dimensional market environment. Throughout this report, we have examined the transformative shifts that are reshaping the clinical safety landscape and identified key market segmentation factors that inform not only the service delivery models but also the end-user strategies.

The growing emphasis on digital innovation and high-throughput data analysis has revolutionized traditional methodologies, enabling faster, more accurate assessments of cardiac safety. Simultaneously, an in-depth understanding of regional dynamics and a keen focus on top-tier industry players have illustrated the global interconnectedness of clinical safety research. These factors collectively underscore the necessity for a forward-thinking, nuanced approach to the challenges and opportunities embedded in the cardiac safety services market.

The insights presented herein affirm that the future of cardiac safety lies in the ability to integrate diverse data sources, technological innovations, and regional considerations into a cohesive strategy that drives patient outcomes while ensuring compliance with stringent regulatory standards. By synthesizing these disparate elements, stakeholders are equipped to navigate an increasingly complex market landscape with confidence and precision.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased incidence of heart-related ailments & rising need for novel drug development globally
      • 5.1.1.2. Rising CRO outsourcing services by pharmaceutical firms
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with integration of cardiac safety technologies with existing healthcare IT infrastructures
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing integration of artificial intelligence and machine learning improving the accuracy of cardiac monitoring
      • 5.1.3.2. Increasing public- private investment in novel clinical research
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory compliance and incentives associated with cardiac safety services
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Service Type: Rising need of holter measurement services for monitoring the drug's effect on cardiac rhythm
    • 5.2.2. Type: Utilization of standalone services due to flexibility and precision in targeting precise cardiac parameters
    • 5.2.3. Application: Preference for drug & device development enhances the detection of cardiac side effects
    • 5.2.4. End User: Innovations in cardiac safety evolving role of contract research organizations in clinical trials
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Safety Services Market, by Service Type

  • 6.1. Introduction
  • 6.2. Blood Pressure Measurement Services
  • 6.3. Cardiovascular Imaging Services
  • 6.4. ECG or Holter Measurement Services
  • 6.5. Thorough QT Studies

7. Cardiac Safety Services Market, by Type

  • 7.1. Introduction
  • 7.2. Integrated Services
  • 7.3. Standalone Services

8. Cardiac Safety Services Market, by Application

  • 8.1. Introduction
  • 8.2. Drug & Device Development
  • 8.3. Regulatory Compliance Requirements

9. Cardiac Safety Services Market, by End User

  • 9.1. Introduction
  • 9.2. Contract Research Organizations
  • 9.3. Pharmaceutical & Biopharma
  • 9.4. Research Institutes

10. Americas Cardiac Safety Services Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cardiac Safety Services Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cardiac Safety Services Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Medera's Novoheart and Curi Bio collaborate for advancements in cardiac drug screening
    • 13.3.2. Lindus Health launches All-in-One cardiovascular CRO for streamlined clinical trials
    • 13.3.3. Medicalgorithmics expands into clinical trials with AI-driven cardiac safety services
    • 13.3.4. CSRC think tank program advancing cardiac safety through remote monitoring and AI integration
    • 13.3.5. Clario and AliveCor partnered to enhance cardiac safety monitoring in decentralized clinical trials
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Banook Group
    • 13.4.2. Clario
    • 13.4.3. ICON PLC
    • 13.4.4. IQVIA Holdings Inc.

Companies Mentioned

  • 1. ACM Global Laboratories
  • 2. Advarra, Inc.
  • 3. Banook Group
  • 4. Biotrial
  • 5. Celerion
  • 6. Certara, Inc.
  • 7. Charles River Laboratories International, Inc.
  • 8. Circle Cardiovascular Imaging Inc.
  • 9. Clario
  • 10. Clyde Biosciences Limited
  • 11. Eurofins Scientific SE
  • 12. GE HealthCare Technologies Inc.
  • 13. ICON PLC
  • 14. IQVIA Holdings Inc.
  • 15. Koninklijke Philips N.V.
  • 16. Laboratory Corporation of America Holdings
  • 17. Medpace, Inc.
  • 18. MERIT CRO, Inc.
  • 19. Metrion Biosciences Limited
  • 20. Ncardia Services B.V.
  • 21. NEXEL Co., Ltd.
  • 22. Octagos Health, Inc.
  • 23. Parexel International Corporation
  • 24. PhysioStim SAS
  • 25. PPD, Inc. by Thermo Fisher Scientific Inc.
  • 26. Richmond Pharmacology Limited
  • 27. Shanghai Medicilon Inc.
  • 28. Worldwide Clinical Trials

LIST OF FIGURES

  • FIGURE 1. CARDIAC SAFETY SERVICES MARKET MULTI-CURRENCY
  • FIGURE 2. CARDIAC SAFETY SERVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. CARDIAC SAFETY SERVICES MARKET RESEARCH PROCESS
  • FIGURE 4. CARDIAC SAFETY SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CARDIAC SAFETY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CARDIAC SAFETY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC SAFETY SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC SAFETY SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY BLOOD PRESSURE MEASUREMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY CARDIOVASCULAR IMAGING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY ECG OR HOLTER MEASUREMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY THOROUGH QT STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY INTEGRATED SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY STANDALONE SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY DRUG & DEVICE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGULATORY COMPLIANCE REQUIREMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. CARDIAC SAFETY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. CARDIAC SAFETY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023